arrows arrow-right arrow-left menu search rss youtube linkedin twitter facebook instagram arrow-play linkedIn

Army Chooses Battelle to Create Vaccines and Therapeutics for Biological and Chemical Threats

Homeland Security Today

Posted on May 23, 2016

Battelle has been selected for a $59 million contract from the US Army Joint Program Executive Office for Chemical and Biological to research and develop vaccines and therapeutics for biological and chemical threats.

The five-year contract was awarded through OASIS, the General Service Administration’s newest contracting vehicle open to all Federal Government agencies worldwide.

Read the full story here

Media Contacts

Katy Delaney
Director, Media Relations
Office: 1.614.424.7208

T.R. Massey

Senior Media Specialist
Office: 1.614.424.5544